Immediate Impact
56 standout
Citing Papers
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)—A Summary of the 2024 Guidelines Update
2024 Standout
Works of F. Attisani being referenced
Sequential BCG and electromotive mitomycin versus BCG alone for high-risk superficial bladder cancer: a randomised controlled trial
2005
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| F. Attisani | 58 | 194 | 25 | 164 | 125 | 18 | 391 | |
| Shahin Chandrasoma | 95 | 286 | 10 | 261 | 73 | 13 | 446 | |
| E. Becht | 88 | 221 | 44 | 150 | 77 | 17 | 439 | |
| Qianyuan Zhuang | 126 | 179 | 16 | 198 | 71 | 27 | 415 | |
| Selina Bhattarai | 116 | 190 | 39 | 94 | 64 | 20 | 359 | |
| Shalva Benjamin | 62 | 153 | 24 | 196 | 41 | 22 | 364 | |
| M. Babjuk | 88 | 263 | 7 | 83 | 73 | 19 | 374 | |
| Fabrizio Verweij | 137 | 274 | 60 | 73 | 135 | 23 | 453 | |
| Kenkichi Saito | 85 | 94 | 96 | 154 | 72 | 15 | 353 | |
| Mark A. Wainstein | 268 | 106 | 60 | 114 | 70 | 15 | 436 | |
| L. Ibarz | 127 | 235 | 25 | 146 | 67 | 14 | 421 |
All Works
Loading papers...